Ruslana Bryk

Years Active: 2020-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Mayako Michino, Alexandre Beautrait, Nicholas A Boyles, Aparna Nadupalli, Alexey Dementiev, Shan Sun, John Ginn, Leigh Baxt, Robert Suto, Ruslana Bryk, Steven V Jerome, David J Huggins, Jeremie Vendome
Shape-Based Virtual Screening of a Billion-Compound Library Identifies Mycobacterial Lipoamide Dehydrogenase Inhibitors. ACS bio & med chem Au 3 (6) (2023)
John Ginn, Xiuju Jiang, Shan Sun, Mayako Michino, David J Huggins, Zodwa Mbambo, Robert Jansen, Kyu Y Rhee, Nancy Arango, Christopher D Lima, Nigel Liverton, Toshihiro Imaeda, Rei Okamoto, Takanobu Kuroita, Kazuyoshi Aso, Andrew Stamford, Michael Foley, Peter T Meinke, Carl Nathan, Ruslana Bryk
Whole Cell Active Inhibitors of Mycobacterial Lipoamide Dehydrogenase Afford Selectivity over the Human Enzyme through Tight Binding Interactions. ACS infectious diseases 7 (2) (2021)
Ruslana Bryk, Shashirekha Mundhra, Xiuju Jiang, Madeleine Wood, Daniel Pfau, Elaina Weber, Suna Park, Li Zhang, Colin Wilson, Renier Van der Westhuyzen, Leslie Street, Kelly Chibale, Matthew Zimmerman, Veronique Anne Dartois, Nunzia Pastore, Andrea Ballabio, Natalie Hawryluk, Stacie Canan, Vikram Khetani, Joseph Camardo, Carl F Nathan
Potentiation of rifampin activity in a mouse model of tuberculosis by activation of host transcription factor EB. PLoS pathogens 16 (6) (2020)

Ruslana Bryk.css-eqlu8i{font-size:small;padding-left:4px;}